BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xue WJ, Feng Y, Wang F, Guo YB, Li P, Wang L, Liu YF, Wang ZW, Yang YM, Mao QS. Asialoglycoprotein receptor-magnetic dual targeting nanoparticles for delivery of RASSF1A to hepatocellular carcinoma. Sci Rep 2016;6:22149. [PMID: 26915683 DOI: 10.1038/srep22149] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
Number Citing Articles
1 Foster T, Lewkowicz M, Quintas C, Ionescu CM, Jones M, Wagle SR, Kovacevic B, Wong EYM, Mooranian A, Al‐salami H. Novel Nanoencapsulation Technology and its Potential Role in Bile Acid‐Based Targeted Gene Delivery to the Inner Ear. Small 2022. [DOI: 10.1002/smll.202204986] [Reference Citation Analysis]
2 Ning Z, Zhao Y, Yan X, Hua Y, Meng Z. Flower-like Composite Material Delivery of Co-Packaged Lenvatinib and Bufalin Prevents the Migration and Invasion of Cholangiocarcinoma. Nanomaterials (Basel) 2022;12:2048. [PMID: 35745387 DOI: 10.3390/nano12122048] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Chakraborty E, Sarkar D. Emerging Therapies for Hepatocellular Carcinoma (HCC). Cancers (Basel) 2022;14. [PMID: 35681776 DOI: 10.3390/cancers14112798] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 19.0] [Reference Citation Analysis]
4 Das SS, Kar S, Singh SK, Hussain A, Verma P, Beg S. Carboxymethyl chitosan in advanced drug-delivery applications. Chitosan in Drug Delivery 2022. [DOI: 10.1016/b978-0-12-819336-5.00006-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Sizikov AA, Nikitin PI, Nikitin MP. Magnetofection In Vivo by Nanomagnetic Carriers Systemically Administered into the Bloodstream. Pharmaceutics 2021;13:1927. [PMID: 34834342 DOI: 10.3390/pharmaceutics13111927] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
6 Al-Mansoori L, Elsinga P, Goda SK. Bio-vehicles of cytotoxic drugs for delivery to tumor specific targets for cancer precision therapy. Biomed Pharmacother 2021;144:112260. [PMID: 34607105 DOI: 10.1016/j.biopha.2021.112260] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Iacobazzi RM, Vischio F, Arduino I, Canepa F, Laquintana V, Notarnicola M, Scavo MP, Bianco G, Fanizza E, Lopedota AA, Cutrignelli A, Lopalco A, Azzariti A, Curri ML, Franco M, Giannelli G, Lee BC, Depalo N, Denora N. Magnetic implants in vivo guiding sorafenib liver delivery by superparamagnetic solid lipid nanoparticles. J Colloid Interface Sci 2021;608:239-54. [PMID: 34626971 DOI: 10.1016/j.jcis.2021.09.174] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
8 Roy B, Ghose S, Biswas S. Therapeutic strategies for miRNA delivery to reduce hepatocellular carcinoma. Semin Cell Dev Biol 2021:S1084-9521(21)00079-3. [PMID: 33926792 DOI: 10.1016/j.semcdb.2021.04.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
9 Al-Nadaf AH, Dahabiyeh LA, Jawarneh S, Bardaweel S, Mahmoud NN. Folic acid-hydrophilic polymer coated mesoporous silica nanoparticles target doxorubicin delivery. Pharm Dev Technol 2021;26:582-91. [PMID: 33729906 DOI: 10.1080/10837450.2021.1904258] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Schneible JD, Daniele MA, Menegatti S. Natural and Synthetic Biopolymers in Drug Delivery and Tissue Engineering. Biopolymers for Biomedical and Biotechnological Applications 2021. [DOI: 10.1002/9783527818310.ch9] [Reference Citation Analysis]
11 Siciliano G, Corricelli M, Iacobazzi RM, Canepa F, Comegna D, Fanizza E, Del Gatto A, Saviano M, Laquintana V, Comparelli R, Mascolo G, Murgolo S, Striccoli M, Agostiano A, Denora N, Zaccaro L, Curri ML, Depalo N. Gold-Speckled SPION@SiO2 Nanoparticles Decorated with Thiocarbohydrates for ASGPR1 Targeting: Towards HCC Dual Mode Imaging Potential Applications. Chemistry 2020;26:11048-59. [PMID: 32628283 DOI: 10.1002/chem.202002142] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
12 Younis MA, Khalil IA, Harashima H. Gene Therapy for Hepatocellular Carcinoma: Highlighting the Journey from Theory to Clinical Applications. Adv Therap 2020;3:2000087. [DOI: 10.1002/adtp.202000087] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
13 Mohammadinejad R, Dehshahri A, Sagar Madamsetty V, Zahmatkeshan M, Tavakol S, Makvandi P, Khorsandi D, Pardakhty A, Ashrafizadeh M, Ghasemipour Afshar E, Zarrabi A. In vivo gene delivery mediated by non-viral vectors for cancer therapy. J Control Release 2020;325:249-75. [PMID: 32634464 DOI: 10.1016/j.jconrel.2020.06.038] [Cited by in Crossref: 82] [Cited by in F6Publishing: 68] [Article Influence: 27.3] [Reference Citation Analysis]
14 Bonferoni MC, Gavini E, Rassu G, Maestri M, Giunchedi P. Chitosan Nanoparticles for Therapy and Theranostics of Hepatocellular Carcinoma (HCC) and Liver-Targeting. Nanomaterials (Basel) 2020;10:E870. [PMID: 32365938 DOI: 10.3390/nano10050870] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
15 Al-nadaf AH, Dahabiyeh LA, Bardaweel S, Mahmoud NN, Jawarneh S. Functionalized mesoporous silica nanoparticles by lactose and hydrophilic polymer as a hepatocellular carcinoma drug delivery system. Journal of Drug Delivery Science and Technology 2020;56:101504. [DOI: 10.1016/j.jddst.2020.101504] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
16 Chew SA, Moscato S, George S, Azimi B, Danti S. Liver Cancer: Current and Future Trends Using Biomaterials. Cancers (Basel) 2019;11:E2026. [PMID: 31888198 DOI: 10.3390/cancers11122026] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
17 Das S, Kudale P, Dandekar P, Devarajan PV. Asialoglycoprotein Receptor and Targeting Strategies. In: Devarajan PV, Dandekar P, D'souza AA, editors. Targeted Intracellular Drug Delivery by Receptor Mediated Endocytosis. Cham: Springer International Publishing; 2019. pp. 353-81. [DOI: 10.1007/978-3-030-29168-6_12] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
18 Elnaggar MH, Abushouk AI, Hassan AHE, Lamloum HM, Benmelouka A, Moatamed SA, Abd-Elmegeed H, Attia S, Samir A, Amr N, Johar D, Zaky S. Nanomedicine as a putative approach for active targeting of hepatocellular carcinoma. Semin Cancer Biol 2021;69:91-9. [PMID: 31421265 DOI: 10.1016/j.semcancer.2019.08.016] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
19 Baig B, Halim SA, Farrukh A, Greish Y, Amin A. Current status of nanomaterial-based treatment for hepatocellular carcinoma. Biomedicine & Pharmacotherapy 2019;116:108852. [DOI: 10.1016/j.biopha.2019.108852] [Cited by in Crossref: 61] [Cited by in F6Publishing: 65] [Article Influence: 15.3] [Reference Citation Analysis]
20 Shah MR, Imran M, Ullah S. Ligand-functionalized nanocarrier-based active drugs targeting for liver cancer therapy. Nanocarriers for Cancer Diagnosis and Targeted Chemotherapy 2019. [DOI: 10.1016/b978-0-12-816773-1.00004-3] [Reference Citation Analysis]
21 Li J, Liang H, Liu J, Wang Z. Poly (amidoamine) (PAMAM) dendrimer mediated delivery of drug and pDNA/siRNA for cancer therapy. Int J Pharm 2018;546:215-25. [PMID: 29787895 DOI: 10.1016/j.ijpharm.2018.05.045] [Cited by in Crossref: 150] [Cited by in F6Publishing: 133] [Article Influence: 30.0] [Reference Citation Analysis]
22 Turato C, Balasso A, Carloni V, Tiribelli C, Mastrotto F, Mazzocca A, Pontisso P. New molecular targets for functionalized nanosized drug delivery systems in personalized therapy for hepatocellular carcinoma. J Control Release 2017;268:184-97. [PMID: 29051062 DOI: 10.1016/j.jconrel.2017.10.027] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 4.2] [Reference Citation Analysis]
23 Xue-hui C, Zhang-qi F, Qian X, Jiang-qiang X, Xian-wen Y, Xi-tai S. Fabrication and evaluation of SDF-1 loaded galactosylated chitosan nanoparticles for liver targeting. Mater Res Express 2017;4:035028. [DOI: 10.1088/2053-1591/4/3/035028] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
24 Liang J, Zhang X, Miao Y, Li J, Gan Y. Lipid-coated iron oxide nanoparticles for dual-modal imaging of hepatocellular carcinoma. Int J Nanomedicine 2017;12:2033-44. [PMID: 28352173 DOI: 10.2147/IJN.S128525] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 4.8] [Reference Citation Analysis]
25 Huh MS, Lee EJ, Koo H, Yhee JY, Oh KS, Son S, Lee S, Kim SH, Kwon IC, Kim K. Polysaccharide-based Nanoparticles for Gene Delivery. Top Curr Chem (Z) 2017;375. [DOI: 10.1007/s41061-017-0114-y] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 5.7] [Reference Citation Analysis]
26 Kuruvilla SP, Tiruchinapally G, ElAzzouny M, ElSayed ME. N-Acetylgalactosamine-Targeted Delivery of Dendrimer-Doxorubicin Conjugates Influences Doxorubicin Cytotoxicity and Metabolic Profile in Hepatic Cancer Cells. Adv Healthc Mater 2017;6. [PMID: 28085993 DOI: 10.1002/adhm.201601046] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
27 Luo C, Chen S, Xu N, Sai WB, Zhao W, Li YC, Hu XJ, Tian H, Gao XD, Yao WB. Establishment of a fluorescence-based method to evaluate endocytosis of desialylated glycoproteins in vitro. Biomed Pharmacother 2017;88:87-94. [PMID: 28095357 DOI: 10.1016/j.biopha.2016.12.085] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
28 Li M, Zhang W, Wang B, Gao Y, Song Z, Zheng QC. Ligand-based targeted therapy: a novel strategy for hepatocellular carcinoma. Int J Nanomedicine 2016;11:5645-69. [PMID: 27920520 DOI: 10.2147/IJN.S115727] [Cited by in Crossref: 86] [Cited by in F6Publishing: 92] [Article Influence: 12.3] [Reference Citation Analysis]